WFH/X
Jul 25, 2025, 05:11
Global Study Sheds Light on Low-Dose Prophylaxis in Hemophilia A
The World Federation of Hemophilia (WFH) shared a post on X:
“A new study using data from WAPPS-Hemo explores the use of low-dose prophylaxis (LDP). The findings show that lower-income countries are more likely to adopt LDP highlighting the urgent need for equitable access.”
Read the full article here.
Title: A Global Cross-Sectional Database Study of Low Dose FVIII SHL Prophylaxis in Haemophilia A
Authors: Dagmar M. Hajducek, Oceana Sinkovic, Pierre Chelle, Alfonso Iorio, Andrea Edginton
Stay informed with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight